MedTrace Logo

Serum Regucalcin Level and Chronic Hepatitis B

NCT05435599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-06-28

No results posted yet for this study

Summary

This study, it was aimed to investigate the relationship between serum regucalcin level and liver fibrosis level in patients with CHB infection.

Conditions

Interventions

DIAGNOSTIC_TEST

Serum regucalcin level

During routine outpatient controls, serum regucalcin level will be measured from the rest of the blood taken for examinations.

Sponsors & Collaborators

  • Konya Meram State Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-12-31
Completion
2021-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05435599 on ClinicalTrials.gov